Co‐localisation of CD93 and MMRN2 expressions has been demonstrated in vessels of a range of different solid human tumours including melanoma, Ewing's sarcoma, ovarian carcinoma and glioma amongst others 166, 167. Here, CD93 is linked to central nervous system cancer.